Drug Research Bias: Ghostwriting, Trial Data, and Patient Protection

Rising ADHD diagnoses track less with patient need than with an industry that profits from every prescription. Against the mainstream default of medication first, this take says drug-company influence biases research and guidelines, and that community-based and behavioral approaches address root causes without pathologizing normal behavior. Skepticism toward profit-driven diagnosis is the starting point for more honest mental health care.

Normal thyroid lab results do not always explain persistent symptoms such as fatigue, brain fog, cold intolerance, or weight changes. This guide explains what standard thyroid tests can and cannot show, how factors such as antibodies, hormone conversion, reference ranges, and test timing may affect interpretation, and which follow-up tests may be worth discussing with a clinician.

Picking a health insurance plan during open enrollment is complicated by confusing processes, affordability challenges, and hidden coverage limits. Plans differ widely in how they handle costs, out-of-network care, and quality measures like diabetes management, while support resources vary in funding and availability. Understanding these differences helps you avoid unexpected denials, fees, and gaps in coverage so you can find a plan that truly fits your needs.

Ultra-processed has become shorthand for bad, but the label lumps fortified staples in with junk food. These claims challenge the panic from different angles: flaws in the NOVA classification, media oversimplification, and cases where processing genuinely adds nutrition. Reading them equips you to judge food quality past the buzzword.